These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2793072)

  • 1. Temporal changes in prolactin and corticosterone response during chronic treatment with d-fenfluramine.
    Serri O; Rasio E
    Horm Res; 1989; 31(4):180-3. PubMed ID: 2793072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of d-fenfluramine on anterior pituitary hormone release in the rat: in vivo and in vitro studies.
    Serri O; Rasio E
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2449-53. PubMed ID: 3449200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
    Van de Kar LD; Urban JH; Richardson KD; Bethea CL
    Neuroendocrinology; 1985 Oct; 41(4):283-8. PubMed ID: 2931613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible relationships between changes in body weight set-point and stress metabolism after treating rats chronically with D-fenfluramine. Effects of feeding rats acutely with fructose on the metabolism of corticosterone, glucose, fatty acids, glycerol and triacylglycerol.
    Brindley DN; Saxton J; Shahidullah H; Armstrong M
    Biochem Pharmacol; 1985 Apr; 34(8):1265-71. PubMed ID: 3994746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats.
    Appel NM; Owens MJ; Culp S; Zaczek R; Contrera JF; Bissette G; Nemeroff CB; De Souza EB
    Endocrinology; 1991 Jun; 128(6):3237-46. PubMed ID: 1645265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to novelty stress in female F344 rats: effects of age and d-fenfluramine treatment.
    Handa RJ; George M; Gordon BH; Campbell DB; Lorens SA
    Pharmacol Biochem Behav; 1996 Mar; 53(3):641-7. PubMed ID: 8866967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine and neurochemical responses to novelty stress in young and old male F344 rats: effects of d-fenfluramine treatment.
    Handa RJ; Cross MK; George M; Gordon BH; Burgess LH; Cabrera TM; Hata N; Campbell DB; Lorens SA
    Pharmacol Biochem Behav; 1993 Sep; 46(1):101-9. PubMed ID: 8255900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA; Sherman BM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
    Vickers SP; Benwell KR; Porter RH; Bickerdike MJ; Kennett GA; Dourish CT
    Br J Pharmacol; 2000 Jul; 130(6):1305-14. PubMed ID: 10903970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of pituitary prolactin and adrenocortical response to ether, formalin or restraint in lactating rats: rise in corticosterone, but no increase in plasma prolactin levels after exposure to stress.
    Bánky Z; Nagy GM; Halász B
    Neuroendocrinology; 1994 Jan; 59(1):63-71. PubMed ID: 8145895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian alterations in prolactin, corticosterone, and thyroid hormone levels and down-regulation of prolactin receptor activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Jones MK; Weisenburger WP; Sipes IG; Russell DH
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):337-50. PubMed ID: 3824389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of normal food intake in rats and dogs and inhibition of experimentally induced hyperphagia in rats by CM 57373 and fenfluramine.
    Miranda GF; Poggesi E; Bianchetti A; Unkovic J; Samanin R
    Eur J Pharmacol; 1988 May; 150(1-2):155-61. PubMed ID: 2456940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction.
    Rezvani AH; Grady DR
    Pharmacol Biochem Behav; 1994 May; 48(1):105-10. PubMed ID: 8029280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the role of TRH and corticosterone in the regulation of prolactin and thyrotrophin secretion during lactation.
    van Haasteren GA; van Toor H; Klootwijk W; Handler B; Linkels E; van der Schoot P; van Ophemert J; de Jong FH; Visser TJ; de Greef WJ
    J Endocrinol; 1996 Feb; 148(2):325-36. PubMed ID: 8699147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent, chronic fenfluramine administration to rats repeatedly suppresses food intake despite substantial brain serotonin reductions.
    Choi S; Jonak EM; Simpson L; Patil V; Fernstrom JD
    Brain Res; 2002 Feb; 928(1-2):30-9. PubMed ID: 11844469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man.
    Barbieri C; Magnoni V; Rauhe WG; Zanasi S; Caldara R; Ferrari C
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):705-10. PubMed ID: 6360431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent administration of d-fenfluramine in rats: paradoxical effects.
    Rozen R; Fumeron F; Betoulle D; Baigts F; Mandenoff A; Fricker J; Apfelbaum M
    Clin Neuropharmacol; 1988; 11 Suppl 1():S105-12. PubMed ID: 3052811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.
    Goodall EM; Cowen PJ; Franklin M; Silverstone T
    Psychopharmacology (Berl); 1993; 112(4):461-6. PubMed ID: 7871058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.